Delivery Order SPE2DB20D3101-SPE2DB25FRGX7

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,304.57 and a completion date of March 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $42,667.02 and a completion date of April 9, 2025. The contract is a firm fixed-price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,119.97 firm fixed-price contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $4,865.73 and a period of performance through May 1, 2025. This contract is not designated as a set-aside and was awarded as a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a firm fixed price, with a ceiling value of $1,286.39, and a period of performance through March 18, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $7,098.00. The contract is a firm fixed-price delivery order, with a period of performance ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $14,924.26 and runs through October 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC covers a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,736.78, is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of June 18, 2025. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $18,786.13 and an ultimate completion date of March 7, 2025. It is for the procurement of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $16,046.05 and a period of performance through April 1, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRGX7
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,638.00. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/15/25, 3:30 PM